COVID-19 Diagnostics Market: Information by Type (Molecular Tests, Serology Tests), Technology (RT-PCR, Isothermal Amplification, CRISPR, ELISA, Hybridization), End-User (Hospitals, Public Health Labs, Private or Commercial Labs) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/9710
COVID-19 Diagnostics Market Overview
COVID-19 Diagnostics Market is expected to register a CAGR of 6.28% to reach USD 96,293.9 Million by 2027. COVID-19 is an infectious disease that is caused by the coronavirus and primarily affects the lungs. Currently, the world is facing COVID-19 pandemic.
Segment Analysis
Global COVID-19 Diagnostics Market has been segmented by Type, Technology, and End Users. The market, based on type, has been bifurcated into molecular tests and serology tests. On the basis of technology, the market has been bifurcated into RT-PCR, isothermal amplification, CRISPR, ELISA, hybridization, and others.
Based on End User, the COVID-19 diagnostics market has been segregated into hospitals, public health labs, private or commercial labs, and others.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/covid-19-diagnostics-market-9710
Key Players
MRFR recognizes the following companies as the Key Players in the Global COVID-19 Diagnostics Market— Becton, Dickinson & Company (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), Biomerieux SA (France), Genmark Diagnostics (US), Thermo Fisher Scientific (US), Qiagen (Germany), and Siemens AG (Germany)
